CRISPR shares the same space as blockchain and IoT payments as one of the most disruptive innovations of recent years. This gene-editing tool has already impacted industries such as biofuel, agriculture, and healthcare, with its global market potential growing exponentially.

The CRISPR: Gene-editing Applications online short course from Harvard's Office of the Vice Provost for Advances in Learning (VPAL), in association with HarvardX, provides you with a comprehensive understanding of the CRISPR Cas9 gene-editing technology, its vast applications, and the market opportunities that genetic engineering presents. With a specific industry focus and through real-world case studies, you’ll explore the applications of CRISPR in biotechnology and how it will assist the development of disease-resistant cultivars, improve food yields, and allow biofuels to become a viable alternative energy source. You’ll analyze the possibilities of curing inherited genetic disorders, treating infectious diseases, and advancing the fight against cancer. Equipped with industry insight into the ethical implications of gene-editing, this course will give you a holistic understanding of the CRISPR landscape and its future potential.

This is not a technical course and no lab skills or prior knowledge of genetic engineering is required to participate. This course gives a comprehensive overview of the CRISPR DNA editing landscape for investors or entrepreneurs looking for the knowledge needed to make strategic business decisions about this disruptive technology. Those working in biotechnology or pharmaceutical product development, sales, or manufacturing will also find value as the content explores the future applications of CRISPR across the economy. Professionals involved in policy and law can also benefit from building a greater understanding of the ethical considerations regarding CRISPR and genetic modification.